An Evaluation of Postapproval CMC Change Timelines
ISPE
SEPTEMBER 10, 2023
Connor Dennis, PhD Roger Nosal 1 September 2023 As the demand for accelerated access to medicines expands globally, the pharmaceutical industry is increasingly submitting regulatory applications in multiple countries simultaneously. The WHO is driving implementation by BoHs of GRP, which will improve regulatory processes.
Let's personalize your content